BioHarvest Sciences Inc. BHST
Set alert
1.66 USD 0.00 0.00%
At close · Oct 30
1.66 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.64 Day range 1.66
1.45 52-week range 9.76
- YTD
- -68.02%
- 1 year
- -82.99%
- Open
- 1.65
- Prev close
- 1.66
- Mkt cap
- 37.63M
- Vol
- 2.54K
- Avg vol
- 39.42K
- EPS
- -0.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.64
- High
- 1.66
- Forward P/E
- 0.00
- Beta
- 1.49
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.70
- 200-d avg
- 4.12
- 1y target
- 14.67
MAX chart
Events in this range
- Nov 25, 2024Earnings: -0.16; estimate -0.05; surprise -220%
Signals (106)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| RSI: Oversold | Aug 10, 2026 | 2 months ago |
| RSI: Oversold | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| RSI: Overbought | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| RSI: Overbought | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| SMA: Bullish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Nov 11, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| MACD: Sell Signal | May 6, 2024 | 2 years ago |
| SMA: Bearish | Apr 22, 2024 | 2 years ago |
| SMA: Bullish | Mar 11, 2024 | 2 years ago |
| RSI: Overbought | Mar 11, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| SMA: Bullish | Oct 16, 2023 | 3 years ago |
| SMA: Bearish | Oct 9, 2023 | 3 years ago |
| SMA: Bullish | Sep 25, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 4, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 7, 2023 | 3 years ago |
| SMA: Bearish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | May 15, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 6, 2023 | 3 years ago |
| SMA: Bearish | Jan 30, 2023 | 3 years ago |
| SMA: Bearish | Jan 30, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| SMA: Bearish | Dec 19, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Dec 5, 2022 | 3 years ago |
| SMA: Bearish | Nov 28, 2022 | 3 years ago |
| SMA: Bullish | Nov 21, 2022 | 3 years ago |
| SMA: Bullish | Nov 14, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 14, 2022 | 3 years ago |
| MACD: Sell Signal | Oct 31, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 24, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 10, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Sep 5, 2022 | 4 years ago |
| SMA: Bullish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 25, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Apr 11, 2022 | 4 years ago |
| SMA: Bearish | Feb 14, 2022 | 4 years ago |
| MACD: Sell Signal | Feb 14, 2022 | 4 years ago |
| SMA: Bullish | Feb 7, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 7, 2022 | 4 years ago |
| SMA: Bearish | Jan 31, 2022 | 4 years ago |
| SMA: Bearish | Jan 31, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 31, 2022 | 4 years ago |
| SMA: Bullish | Jan 24, 2022 | 4 years ago |
| SMA: Bullish | Jan 24, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
| SMA: Bullish | Dec 6, 2021 | 4 years ago |
| SMA: Bullish | Dec 6, 2021 | 4 years ago |
| SMA: Bearish | Nov 29, 2021 | 4 years ago |
| SMA: Bearish | Nov 29, 2021 | 4 years ago |
| SMA: Bullish | Oct 25, 2021 | 5 years ago |
| SMA: Bullish | Oct 18, 2021 | 5 years ago |
| SMA: Bearish | Sep 6, 2021 | 5 years ago |
| SMA: Bullish | Jul 5, 2021 | 5 years ago |
| SMA: Bearish | Mar 15, 2021 | 5 years ago |
Key statistics
- Market cap
- 105.70M
- Enterprise value
- 114.38M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 5.53
- Price / book
- 0.00
- EPS (TTM)
- -1.28
- Beta
- 1.49
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -84.84%
- Revenue (TTM)
- 19.13M
- Revenue growth
- 119.20%
- Free cash flow
- -5.96M
- Total cash
- 5.17M
- Total debt
- 10.39M
- Return on equity
- -5955.96%
- Shares outstanding
- 17.33M
- Short % of float
- 0.00%
- 50-day average
- 5.70
- 200-day average
- 4.12
Analyst view
Consensus: buy
Buy
Price target (mean) 14.67 +783.5% upside
Now 1.66
- Target (low)
- 12.00
- Target (mean)
- 14.67
- Target (high)
- 18.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.14.
Financials — quick view
BHST Revenue — quarterly 8.84M
BHST Net income — quarterly -3.71M
BHST EPS — quarterly -0.17
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 25, 2024 | Sep 1, 2024 | -0.05 | -0.16 | -0.11 | -220.00% |
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
- Country
- Canada
- Website
- bioharvest.com
News
- BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026
- BioHarvest takes second plant-cell asset to commercial readiness
- BioHarvest Sciences' Proprietary Olive Cell Composition Attains Commercial Readiness, Now Available For Licensing And Commercialization
- BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity
- BioHarvest says its platform can produce target sweetener in Tate & Lyle program
- Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
- BioHarvest Sciences launches buyback of up to 5% of shares
- BioHarvest Sciences Board Authorizes Normal Course Issuer Bid To Repurchase Up To 5% Of Outstanding Common Shares
- BioHarvest Sciences Announces Share Repurchase Program
- BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
Your note
Sign in to keep a note on BHST — it syncs with the Stock Master app.